Epigenetics Market to climb to $16.3bn

Posted: 10/29/2015

A new research report from Grand View Research inc, charts that the international epigenetics market is due to reach US$16.31 billion by 2022. The forecasted growth being fuelled by the increasing focus on cancer and other disease treatments with epigenetic modification bases. The pharma industry is expected to be drawn towards collaboration

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Posted: 10/29/2015

Pharma IQ Members


The Hurlingham Club, London, United Kingdom
January 21 - 23, 2018
Twickenham Stadium, London, United Kingdom
January 28 - 31, 2018